Stock listing
Alto Neuroscience, Inc.
Selected listing: ANRO · NYSE · USD · US
Alto Neuroscience, Inc. (NYSE:ANRO), Health Technology. Latest release Aug 27, 2026: Alto Neuroscience Promotes Nick Smith to President and Chief Financial…
- Ticker
- NYSE:ANRO
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NYSE
- Currency
- USD
About Alto Neuroscience, Inc.
Alto Neuroscience, Inc. (ticker: ANRO) is a public company based in the United States, focusing on innovative solutions in the field of neuroscience. The company is committed to developing therapies that address unmet medical needs in mental health.
Latest news from Alto Neuroscience, Inc.
Alto Neuroscience Promotes Nick Smith to President and Chief Financial Officer
August 27, 2026
Alto Neuroscience Reports Second Quarter 2026 Financial Results and Recent Business Highlights
August 12, 2026
Alto Neuroscience Announces Pricing of $100.0 Million Underwritten Registered Direct Offering of Common Stock
July 13, 2026
Alto Neuroscience Highlights Nature Medicine Publication Demonstrating Significant Effects of Pramipexole on Anhedonia
June 15, 2026
Alto Neuroscience Appoints Karuna Therapeutics Founder Andrew Miller, Ph.D. to Board of Directors
May 28, 2026
Research Alto Neuroscience, Inc.
Alto Neuroscience, Inc. company profile
View the public company page for Alto Neuroscience, Inc. on 6ix.
Alto Neuroscience, Inc. news
Read company news and market updates connected to Alto Neuroscience, Inc..
Alto Neuroscience, Inc. investor events
Find investor webinars, events, and replay context for Alto Neuroscience, Inc..